News | Treatment Planning | July 05, 2018

RayStation treatment planning system allows advanced intensity modulated proton therapy planning

MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan

July 5, 2018 — MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment planning system in combination with Mevion’s Hyperscan pencil beam scanning system. This was the world’s first treatment carried out on the Mevion S250i Proton Therapy System, according to Mevion.

The combination of RayStation and Mevion’s Hyperscan technology enables clinicians at MedStar Georgetown to plan and treat patients with the advantage of very sharp field edges and minimized radiation to critical structures.

RayStation enables the use of advanced intensity modulated proton therapy (IMPT) capabilities that are unique to the Hyperscan technology. These capabilities include multi-leaf collimation with Mevion’s Adaptive Aperture, a proton multi-leaf collimator (pMLC) designed to achieve sharp lateral dose gradients and protect sensitive organs at every energy layer of the treatment.

For more information: www.raysearchlabs.com


Additional Content

News | Radiation Oncology

Oct. 12, 2026 — RWJBarnabas Health and Rutgers Cancer Institute have earned a systemwide accreditation from the American ...

Time October 13, 2026
arrow
News | Radiation Therapy

Oct. 1, 2026 — At ASTRO 2026 Elekta highlighted new data showing unprecedented long-term survival outcomes for patients ...

Time October 05, 2026
arrow
News | Stereotactic Body Radiation Therapy (SBRT)

Sept. 27, 2026 — Siemens Healthineers recently launched Accela, a radiotherapy solution engineered around NeoArc ...

Time October 01, 2026
arrow
News | Molecular Imaging

Sept. 22, 2026 — Blue Earth Diagnostics, a part of the Bracco Group, has announced new research examining how precision ...

Time September 23, 2026
arrow
News | Radiation Oncology

Sept. 2, 2026 — Children with one of the deadliest forms of brain cancer may benefit from an additional course of ...

Time September 03, 2026
arrow
Subscribe Now